• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨甲蝶呤全身治疗与腹腔镜手术治疗输卵管妊娠的成功率和自发性妊娠率:一项随机试验。

Success and spontaneous pregnancy rates following systemic methotrexate versus laparoscopic surgery for tubal pregnancies: a randomized trial.

机构信息

Department of Obstetrics and Gynecology, Hvidovre Hospital, Hvidovre, Denmark.

出版信息

Acta Obstet Gynecol Scand. 2009;88(12):1331-7. doi: 10.3109/00016340903188912.

DOI:10.3109/00016340903188912
PMID:19961341
Abstract

OBJECTIVE

To determine which treatment should be offered to women with a non-ruptured tubal pregnancy: a single dose of methotrexate (MTX) or laparoscopic surgery.

DESIGN

Prospective, randomized, open multicenter study.

SETTING

Seven Danish departments of obstetrics and gynecology.

SAMPLE

A total of 106 women diagnosed with ectopic pregnancy (EP).

METHODS

Between March 1997 and September 2000, 1,265 women were diagnosed with EP, 395 (31%) were eligible, 109 (9%) were randomized of whom 106 had an EP. The study was originally powered to a sample size of 422 patients. The women were randomized to either medical (MTX; 53) or surgical (laparoscopic salpingotomy; 53) treatment. Follow-up by questionnaire and through national patient databases for a maximum of 10 years.

MAIN OUTCOME MEASURES

Uneventful decline of plasma-human chorionic gonadotropin to less than 5 IU/L, rates of spontaneous, subsequent intrauterine, and recurrent ectopic pregnancies.

RESULTS

The success rates were 74% following MTX treatment and 87% after surgery (n.s.); the subsequent spontaneous intrauterine pregnancy rate was 73% after MTX and 62% after surgery; and the EP rate was 9.6% after MTX and 17.3% following surgery (n.s.).

CONCLUSIONS

In women with an EP, who are hemodynamically stable and wishing to preserve their fertility, medical treatment with single dose MTX tends to be equal to treatment with laparoscopic surgery regarding success rate, complications, and subsequent fertility. Although the two treatment modalities seemed to be similar in outcome, it is crucial that the diagnosis is based on a high-quality ultrasonographic evaluation, as two patients had intrauterine pregnancies despite fulfilling the diagnostic algorithm for EP.

摘要

目的

确定应向未破裂输卵管妊娠(EP)的妇女提供哪种治疗方法:单次甲氨蝶呤(MTX)或腹腔镜手术。

设计

前瞻性、随机、开放的多中心研究。

地点

丹麦 7 个妇产科部门。

样本

共 106 名诊断为异位妊娠(EP)的妇女。

方法

1997 年 3 月至 2000 年 9 月,共诊断出 1265 名 EP 妇女,其中 395 名(31%)符合条件,109 名(9%)被随机分配,其中 106 名患有 EP。该研究最初的样本量为 422 名患者。妇女被随机分为药物(MTX;53 例)或手术(腹腔镜输卵管切开术;53 例)治疗组。通过问卷调查和国家患者数据库进行为期最长 10 年的随访。

主要观察指标

人绒毛膜促性腺激素(hCG)血浆水平降至 5IU/L 以下,自发、随后的宫内和复发性 EP 的发生率。

结果

MTX 治疗后成功率为 74%,手术治疗后成功率为 87%(无统计学差异);MTX 治疗后自发宫内妊娠率为 73%,手术治疗后为 62%;MTX 治疗后 EP 发生率为 9.6%,手术治疗后为 17.3%(无统计学差异)。

结论

对于血流动力学稳定且希望保持生育能力的 EP 妇女,单次剂量 MTX 药物治疗在成功率、并发症和随后的生育能力方面与腹腔镜手术治疗相当。虽然这两种治疗方法的结果似乎相似,但关键是诊断基于高质量的超声评估,因为有两名患者尽管符合 EP 的诊断算法,但仍发生了宫内妊娠。

相似文献

1
Success and spontaneous pregnancy rates following systemic methotrexate versus laparoscopic surgery for tubal pregnancies: a randomized trial.氨甲蝶呤全身治疗与腹腔镜手术治疗输卵管妊娠的成功率和自发性妊娠率:一项随机试验。
Acta Obstet Gynecol Scand. 2009;88(12):1331-7. doi: 10.3109/00016340903188912.
2
A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy.一项比较单剂量全身应用甲氨蝶呤与腹腔镜手术治疗未破裂输卵管妊娠的随机试验。
BJOG. 2001 Feb;108(2):192-203. doi: 10.1111/j.1471-0528.2001.00038.x.
3
Treatment of tubal pregnancy in the netherlands: an economic comparison of systemic methotrexate administration and laparoscopic salpingostomy.荷兰输卵管妊娠的治疗:全身应用甲氨蝶呤与腹腔镜输卵管造口术的经济学比较
Am J Obstet Gynecol. 1999 Oct;181(4):945-51. doi: 10.1016/s0002-9378(99)70330-3.
4
Ectopic pregnancy; risk factors and comparison of intervention success rates in tubal ectopic pregnancy.异位妊娠;危险因素及输卵管异位妊娠干预成功率的比较
Clin Exp Obstet Gynecol. 2011;38(1):67-70.
5
Medical management of ectopic pregnancy with single-dose and 2-dose methotrexate protocols: human chorionic gonadotropin trends and patient outcomes.单剂量和双剂量甲氨蝶呤方案治疗异位妊娠的医学管理:人绒毛膜促性腺激素变化趋势及患者预后
Am J Obstet Gynecol. 2016 Nov;215(5):590.e1-590.e5. doi: 10.1016/j.ajog.2016.06.040. Epub 2016 Jun 28.
6
Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.甲氨蝶呤或期待疗法治疗血清人绒毛膜促性腺激素浓度低的异位妊娠或不明位置妊娠妇女?一项随机比较。
Hum Reprod. 2013 Jan;28(1):60-7. doi: 10.1093/humrep/des373. Epub 2012 Oct 18.
7
Methotrexate injection of tubal ectopic pregnancy. A logical evolution?
Med J Aust. 1991 Apr 1;154(7):469-71.
8
The METEX study: methotrexate versus expectant management in women with ectopic pregnancy: a randomised controlled trial.METEX研究:甲氨蝶呤与异位妊娠女性期待治疗的对比:一项随机对照试验
BMC Womens Health. 2008 Jun 19;8:10. doi: 10.1186/1472-6874-8-10.
9
[Analysis of pregnancy rates after treatment of tubal pregnancy with systemic methotrexate].[甲氨蝶呤全身治疗输卵管妊娠后妊娠率分析]
Zhonghua Fu Chan Ke Za Zhi. 2001 Sep;36(9):534-5.
10
Methotrexate vs placebo in early tubal ectopic pregnancy: a multi- centre double-blind randomised trial.甲氨蝶呤与安慰剂治疗早期输卵管异位妊娠的多中心双盲随机试验
Rev Recent Clin Trials. 2012 Aug;7(3):238-43. doi: 10.2174/157488712802281321.

引用本文的文献

1
Comparison of laparoscopic tubal-preserving surgical management versus methotrexate therapy for tubal pregnancy: A conventional and network meta-analysis.腹腔镜保留输卵管手术治疗与甲氨蝶呤治疗输卵管妊娠的比较:传统和网状荟萃分析
PLoS One. 2025 Sep 12;20(9):e0332169. doi: 10.1371/journal.pone.0332169. eCollection 2025.
2
Ectopic pregnancy.异位妊娠
Nat Rev Dis Primers. 2024 Dec 12;10(1):94. doi: 10.1038/s41572-024-00579-x.
3
Tubal Pathologies and Fertility Outcomes: A Review.输卵管病理与生育结局:综述
Cureus. 2023 May 11;15(5):e38881. doi: 10.7759/cureus.38881. eCollection 2023 May.
4
Reproductive outcomes of ectopic pregnancy with conservative and surgical treatment: A systematic review and meta-analysis.保守治疗和手术治疗异位妊娠的妊娠结局:系统评价和荟萃分析。
Medicine (Baltimore). 2023 Apr 25;102(17):e33621. doi: 10.1097/MD.0000000000033621.
5
Factors Associated with Ruptured Ectopic Pregnancy: A 10-Year Review at a District Hospital in Ghana.与异位妊娠破裂相关的因素:加纳一家区级医院的十年回顾
Obstet Gynecol Int. 2022 Mar 7;2022:1491419. doi: 10.1155/2022/1491419. eCollection 2022.
6
FERTILITY OUTCOMES AFTER MEDICAL AND SURGICAL MANAGEMENT OF TUBAL ECTOPIC PREGNANCY.输卵管妊娠的医疗和手术治疗后的生育结局。
Acta Clin Croat. 2022 Feb;60(3):347-353. doi: 10.20471/acc.2021.60.03.02.
7
A Model to Predict Treatment Failure of Single‑Dose Methotrexate in Patients with Tubal Pregnancy.单次甲氨蝶呤治疗输卵管妊娠失败的预测模型。
Med Sci Monit. 2020 May 8;26:e920079. doi: 10.12659/MSM.920079.
8
Two-dose versus single-dose methotrexate for treatment of ectopic pregnancy: a meta-analysis.两剂与单剂甲氨蝶呤治疗异位妊娠的疗效比较:一项荟萃分析。
Am J Obstet Gynecol. 2019 Aug;221(2):95-108.e2. doi: 10.1016/j.ajog.2019.01.002. Epub 2019 Jan 7.
9
A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol.甲氨蝶呤与吉非替尼联合用药对比单用甲氨蝶呤治疗输卵管异位妊娠的多中心、双盲、安慰剂对照随机试验(GEM3):试验方案
Trials. 2018 Nov 20;19(1):643. doi: 10.1186/s13063-018-3008-6.
10
The impact of expectant management, systemic methotrexate and surgery on subsequent pregnancy outcomes in tubal ectopic pregnancy.期待治疗、全身应用甲氨蝶呤及手术对输卵管异位妊娠后续妊娠结局的影响。
Ir J Med Sci. 2017 May;186(2):387-392. doi: 10.1007/s11845-016-1419-5. Epub 2016 Feb 19.